These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10985613)

  • 1. A comparative study of genotoxic effects in the treatment of trichomonas vaginalis infection: metronidazole or nalidixic acid.
    Akyol D; Mungan T; Baltaci V
    Arch Gynecol Obstet; 2000 Jul; 264(1):20-3. PubMed ID: 10985613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis.
    Wendel KA; Erbelding EJ; Gaydos CA; Rompalo AM
    Clin Infect Dis; 2002 Sep; 35(5):576-80. PubMed ID: 12173132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing vaginal trichomoniasis resistant to high-dose metronidazole therapy.
    Lewis DA; Habgood L; White R; Barker KF; Murphy SM
    Int J STD AIDS; 1997 Dec; 8(12):780-4. PubMed ID: 9433954
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.
    Forbes GL; Drayton R; Forbes GD
    Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.
    Kissinger P; Mena L; Levison J; Clark RA; Gatski M; Henderson H; Schmidt N; Rosenthal SL; Myers L; Martin DH
    J Acquir Immune Defic Syndr; 2010 Dec; 55(5):565-71. PubMed ID: 21423852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premature with trichomoniasis: report of one case.
    Wang JJ; Yeung LK; Sun LC; Sy LB; Leu FJ
    Acta Paediatr Taiwan; 2005; 46(4):219-21. PubMed ID: 16381336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.
    Cudmore SL; Delgaty KL; Hayward-McClelland SF; Petrin DP; Garber GE
    Clin Microbiol Rev; 2004 Oct; 17(4):783-93, table of contents. PubMed ID: 15489348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection.
    Klebanoff MA; Carey JC; Hauth JC; Hillier SL; Nugent RP; Thom EA; Ernest JM; Heine RP; Wapner RJ; Trout W; Moawad A; Leveno KJ; Miodovnik M; Sibai BM; Van Dorsten JP; Dombrowski MP; O'Sullivan MJ; Varner M; Langer O; McNellis D; Roberts JM;
    N Engl J Med; 2001 Aug; 345(7):487-93. PubMed ID: 11519502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro cytotoxic effects of ornidazole, metronidazole and ciprofloxacin against Trichomonas vaginalis trophozoites.
    Inceboz T; Inceboz U; Ozturk S
    J Chemother; 2004 Oct; 16(5):459-62. PubMed ID: 15565912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC; Bachmann LH; Hobbs MM
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nimorazole compared with metronidazole in the treatment of vaginal trichomoniasis.
    Tinkler AE
    Practitioner; 1974 Jan; 212(267):115-9. PubMed ID: 4591199
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study for the evaluation of the efficacy and safety of metronidazole and secnidazole in the treatment of vaginal trichomoniasis].
    Buitrón García Figueroa R; Gonzalo Butrón López F; Oropez Rechy G; Romero-Cabello R
    Ginecol Obstet Mex; 1997 Nov; 65():487-91. PubMed ID: 9441152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicogenetic evaluation of metronidazole in the treatment of women infected with Trichomonas vaginalis.
    Carballo MA; Palermo AM; Mudry MD
    Ann Trop Med Parasitol; 2004 Mar; 98(2):139-47. PubMed ID: 15035724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenical pessaries in the treatment of metronidazole-resistant Trichomonas vaginalis.
    Walker PP; Hall RE; Wilson JD
    Int J STD AIDS; 1997 Jul; 8(7):473. PubMed ID: 9228600
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of metronidazole-resistant Trichomonas vaginalis--a new approach.
    Mammen-Tobin A; Wilson JD
    Int J STD AIDS; 2005 Jul; 16(7):488-90. PubMed ID: 16004628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of intravaginal nonoxynol 9 versus oral metronidazole in the treatment of vaginal trichomoniasis.
    Antonelli NM; Diehl SJ; Wright JW
    Am J Obstet Gynecol; 2000 May; 182(5):1008-10. PubMed ID: 10819810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistant trichomoniasis: successful treatment with combination therapy.
    Nyirjesy P; Gilbert J; Mulcahy LJ
    Sex Transm Dis; 2011 Oct; 38(10):962-3. PubMed ID: 21934573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous metronidazole, liquid tinidazole, and intra-vaginal boric acid to cure trichomonas in a patient with gastric bypass surgery.
    Butt S; Tirmizi A
    Int J STD AIDS; 2018 Jul; 29(8):825-827. PubMed ID: 29393008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.
    Sobel JD; Nyirjesy P; Brown W
    Clin Infect Dis; 2001 Oct; 33(8):1341-6. PubMed ID: 11565074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.
    Van Der Pol B; Williams JA; Orr DP; Batteiger BE; Fortenberry JD
    J Infect Dis; 2005 Dec; 192(12):2039-44. PubMed ID: 16288365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.